CA
NZ
UK
AU
IND
US
Mesa Laboratories, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting second-quarter and first-half financial results for fiscal year 2027.
Affiliated Managers Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting consolidated revenue, earnings, and balance sheet data for the third quarter and first nine months of the fiscal year.
Hawthorn Bancshares, Inc. filed its Form 10-Q with the SEC on November 9, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, including net income of $7.062 million and total assets of $2.141 billion.
International Money Express, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission covering the period ended September 30, 2026, disclosing financial statements, management discussion, and risk factors including a pending acquisition by The Western Union Company.
Hims & Hers Health, Inc. filed a Form 8-K on November 9, 2026, disclosing the appointment of Dr. Andrew Huberman, age 51, to its board of directors effective November 4, 2026, along with two related commercial agreements totaling up to $9,500,000 per year in …
FreightCar America, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission covering the quarterly period ended September 30, 2026, reporting condensed consolidated financial statements and related disclosures.
Lineage, Inc., a Maryland-incorporated real estate investment trust focused on temperature-controlled warehousing, filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing 227,750,422 shares of common stock outstanding as of November 3, 2026.
World Acceptance Corporation filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing consolidated financial statements and related notes for the second quarter of fiscal year 2027.
Hims & Hers Health, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the period ended September 30, 2026, disclosing substantial growth in total assets and significant changes to its balance sheet compared to December 31, 2025.
ArriVent Biopharma, Inc. filed its quarterly report with the SEC on November 9, 2026, covering the fiscal period ended September 30, 2026.
Please wait processing your request...